- Home
- AROW vs AQST Comparison
AROW vs AQST Comparison
Compare AROW & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AROW
- AQST
- Stock Information
- Founded
- AROW 1851
- AQST 2004
- Country
- AROW United States
- AQST United States
- Employees
- AROW N/A
- AQST N/A
- Industry
- AROW Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- AROW Finance
- AQST Health Care
- Exchange
- AROW Nasdaq
- AQST Nasdaq
- Market Cap
- AROW 563.2M
- AQST 502.6M
- IPO Year
- AROW N/A
- AQST 2018
- Fundamental
- Price
- AROW $33.65
- AQST $4.41
- Analyst Decision
- AROW Hold
- AQST Strong Buy
- Analyst Count
- AROW 1
- AQST 7
- Target Price
- AROW N/A
- AQST $9.43
- AVG Volume (30 Days)
- AROW 48.0K
- AQST 1.7M
- Earning Date
- AROW 10-31-2024
- AQST 11-04-2024
- Dividend Yield
- AROW 3.33%
- AQST N/A
- EPS Growth
- AROW N/A
- AQST N/A
- EPS
- AROW 1.96
- AQST N/A
- Revenue
- AROW $136,138,000.00
- AQST $58,900,000.00
- Revenue This Year
- AROW N/A
- AQST $18.45
- Revenue Next Year
- AROW $13.65
- AQST N/A
- P/E Ratio
- AROW $17.17
- AQST N/A
- Revenue Growth
- AROW 1.35
- AQST 22.56
- 52 Week Low
- AROW $21.50
- AQST $1.69
- 52 Week High
- AROW $34.63
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- AROW 67.10
- AQST 37.69
- Support Level
- AROW $31.51
- AQST $4.62
- Resistance Level
- AROW $34.51
- AQST $5.59
- Average True Range (ATR)
- AROW 1.10
- AQST 0.37
- MACD
- AROW 0.38
- AQST -0.11
- Stochastic Oscillator
- AROW 85.20
- AQST 2.54
About AROW Arrow Financial Corporation
Arrow Financial Corp is a holding company. The company provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.